Search research articles
Contact Us
Filters
Showing results (271-280 of 309) with videos related to
Page
of 31
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
July 15, 2026
External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection
Clarissa Julia Schmidt, Florian C Gaertner, Barbara Kreppel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2021
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Ligand After <sup>223</sup>Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
Oliver Sartor, Christian la Fougère, Markus Essler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 9, 2012
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest
Mario Vallon, Christof Seidl, Birgit Blechert, et al.
International Journal of Endocrinology
|
February 25, 2020
Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases
Karin Mayer, Selina Kiry, Anna Yordanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial
Philipp Krausewitz, Markus Essler, Florian C Gaertner, et al.
Scientific Reports
|
June 24, 2024
Clinical experience with shear wave elastography (SWE) for assessing healthy uterus in a transabdominal approach
Judith M Stader, Florian Recker, Tolga Tonguc, et al.
Scientific Reports
|
July 14, 2026
Habenula volume alterations in adults born very preterm
Theresa Stüwe, Angelika Maurer, Marcel Daamen, et al.
European Radiology
|
November 29, 2024
Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers
Sara Dohmen, Florian Recker, Yoana Ivanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 27, 2022
Safety and Survival Outcomes of <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior <sup>223</sup>Ra treatment: The RALU Study
Kambiz Rahbar, Markus Essler, Kim M Pabst, et al.
Oncotarget
|
January 11, 2015
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma
Katharina Teiluf, Christof Seidl, Birgit Blechert, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 309) with videos related to
Sort By:
Page
of 31
European Journal of Nuclear Medicine and Molecular Imaging
|
July 15, 2026
External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection
Clarissa Julia Schmidt, Florian C Gaertner, Barbara Kreppel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2021
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Ligand After <sup>223</sup>Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
Oliver Sartor, Christian la Fougère, Markus Essler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 9, 2012
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest
Mario Vallon, Christof Seidl, Birgit Blechert, et al.
International Journal of Endocrinology
|
February 25, 2020
Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases
Karin Mayer, Selina Kiry, Anna Yordanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial
Philipp Krausewitz, Markus Essler, Florian C Gaertner, et al.
Scientific Reports
|
June 24, 2024
Clinical experience with shear wave elastography (SWE) for assessing healthy uterus in a transabdominal approach
Judith M Stader, Florian Recker, Tolga Tonguc, et al.
Scientific Reports
|
July 14, 2026
Habenula volume alterations in adults born very preterm
Theresa Stüwe, Angelika Maurer, Marcel Daamen, et al.
European Radiology
|
November 29, 2024
Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers
Sara Dohmen, Florian Recker, Yoana Ivanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 27, 2022
Safety and Survival Outcomes of <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior <sup>223</sup>Ra treatment: The RALU Study
Kambiz Rahbar, Markus Essler, Kim M Pabst, et al.
Oncotarget
|
January 11, 2015
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma
Katharina Teiluf, Christof Seidl, Birgit Blechert, et al.
Page
of 31